Literature DB >> 9832490

Effects of inhaled nitric oxide and oxygen in high-altitude pulmonary edema.

I S Anand1, B A Prasad, S S Chugh, K R Rao, D N Cornfield, C E Milla, N Singh, S Singh, W Selvamurthy.   

Abstract

BACKGROUND: High-altitude pulmonary edema (HAPE) is characterized by pulmonary hypertension, increased pulmonary capillary permeability, and hypoxemia. Treatment is limited to descent to lower altitude and administration of oxygen. METHODS AND
RESULTS: We studied the acute effects of inhaled nitric oxide (NO), 50% oxygen, and a mixture of NO plus 50% oxygen on hemodynamics and gas exchange in 14 patients with HAPE. Each gas mixture was given in random order for 30 minutes followed by 30 minutes washout with room air. All patients had severe HAPE as judged by Lake Louise score (6.4+/-0.7), PaO2 (35+/-3. 1 mm Hg), and alveolar to arterial oxygen tension difference (AaDO2) (26+/-3 mm Hg). NO had a selective effect on the pulmonary vasculature and did not alter systemic hemodynamics. Compared with room air, pulmonary vascular resistance fell 36% with NO (P<0.001), 23% with oxygen (P<0.001 versus air, P<0.05 versus NO alone), and 54% with NO plus 50% oxygen (P<0.001 versus air, P<0.005 versus oxygen and versus NO). NO alone improved PaO2 (+14%) and AaDO2 (-31%). Compared with 50% oxygen alone, NO plus 50% oxygen had a greater effect on AaDO2 (-18%) and PaO2 (+21%).
CONCLUSIONS: Inhaled NO may have a therapeutic role in the management of HAPE. The combined use of inhaled NO and oxygen has additive effects on pulmonary hemodynamics and even greater effects on gas exchange. These findings indicate that oxygen and NO may act on separate but interactive mechanisms in the pulmonary vasculature.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832490     DOI: 10.1161/01.cir.98.22.2441

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

Review 1.  Nitric oxide in adaptation to altitude.

Authors:  Cynthia M Beall; Daniel Laskowski; Serpil C Erzurum
Journal:  Free Radic Biol Med       Date:  2012-01-20       Impact factor: 7.376

Review 2.  High altitude and free radicals.

Authors:  Tibor Bakonyi; Zsolt Radak
Journal:  J Sports Sci Med       Date:  2004-06-01       Impact factor: 2.988

3.  Phosphodiesterase type 5 and high altitude pulmonary hypertension.

Authors:  A A Aldashev; B K Kojonazarov; T A Amatov; T M Sooronbaev; M M Mirrakhimov; N W Morrell; J Wharton; M R Wilkins
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

Review 4.  Physiology and pathophysiology at high altitude: considerations for the anesthesiologist.

Authors:  Kay B Leissner; Feroze U Mahmood
Journal:  J Anesth       Date:  2009-11-18       Impact factor: 2.078

Review 5.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

Review 6.  Interventions for treating acute high altitude illness.

Authors:  Daniel Simancas-Racines; Ingrid Arevalo-Rodriguez; Dimelza Osorio; Juan Va Franco; Yihan Xu; Ricardo Hidalgo
Journal:  Cochrane Database Syst Rev       Date:  2018-06-30

7.  Reducing TRPC1 Expression through Liposome-Mediated siRNA Delivery Markedly Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension in a Murine Model.

Authors:  Cheuk-Kwan Sun; Yen-Yi Zhen; Hung-I Lu; Pei-Hsun Sung; Li-Teh Chang; Tzu-Hsien Tsai; Jiunn-Jye Sheu; Yung-Lung Chen; Sarah Chua; Hsueh-Wen Chang; Yi-Ling Chen; Fan-Yen Lee; Hon-Kan Yip
Journal:  Stem Cells Int       Date:  2014-12-18       Impact factor: 5.443

8.  High-altitude Pulmonary Hypertension: an Update on Disease Pathogenesis and Management.

Authors:  Aibek E Mirrakhimov; Kingman P Strohl
Journal:  Open Cardiovasc Med J       Date:  2016-02-08

9.  Non-cardiogenic acute pulmonary edema in elderly patient with Dressler syndrome associated pulmonary embolism.

Authors:  Hui-Chun Yu; Xiao-Bing Ma; Zhen-Qing Wang; Hui-Jun Xu; Ping Wang; Feng-Ping An; Yu-Chuan Hu; Guang-Bin Cui; Xu-Fang Bai; He Li
Journal:  J Geriatr Cardiol       Date:  2016-12       Impact factor: 3.327

10.  Novel drugs in the management of acute mountain sickness and high altitude pulmonary edema.

Authors:  Gaurav Sikri; Anirban Bhattacharya
Journal:  Open Access J Sports Med       Date:  2015-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.